KR102431443B1 - Composition for improving skin wrinkles and elasticity containing the extract of Hibiseu Smanihot L. - Google Patents
Composition for improving skin wrinkles and elasticity containing the extract of Hibiseu Smanihot L. Download PDFInfo
- Publication number
- KR102431443B1 KR102431443B1 KR1020200138343A KR20200138343A KR102431443B1 KR 102431443 B1 KR102431443 B1 KR 102431443B1 KR 1020200138343 A KR1020200138343 A KR 1020200138343A KR 20200138343 A KR20200138343 A KR 20200138343A KR 102431443 B1 KR102431443 B1 KR 102431443B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- geumhwagyu
- weight
- parts
- radish
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 85
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 230000037303 wrinkles Effects 0.000 title claims abstract description 23
- 229940092385 radish extract Drugs 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 59
- 230000036541 health Effects 0.000 claims description 30
- 239000002537 cosmetic Substances 0.000 claims description 25
- 235000013376 functional food Nutrition 0.000 claims description 25
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 21
- 235000013402 health food Nutrition 0.000 claims description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 18
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 11
- 241000220259 Raphanus Species 0.000 claims description 10
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 230000037394 skin elasticity Effects 0.000 claims description 9
- 235000005733 Raphanus sativus var niger Nutrition 0.000 claims description 7
- 244000155437 Raphanus sativus var. niger Species 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 230000006872 improvement Effects 0.000 claims description 4
- 210000001626 skin fibroblast Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 15
- 230000037319 collagen production Effects 0.000 abstract description 8
- 230000002195 synergetic effect Effects 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000014509 gene expression Effects 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 27
- 108010035532 Collagen Proteins 0.000 description 26
- 102000008186 Collagen Human genes 0.000 description 25
- 229920001436 collagen Polymers 0.000 description 24
- 239000013543 active substance Substances 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 16
- 230000002500 effect on skin Effects 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000013355 food flavoring agent Nutrition 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 101150008656 COL1A1 gene Proteins 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 6
- 101001011906 Homo sapiens Matrix metalloproteinase-14 Proteins 0.000 description 6
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 238000003753 real-time PCR Methods 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 102100030216 Matrix metalloproteinase-14 Human genes 0.000 description 5
- 235000013365 dairy product Nutrition 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 4
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000011158 quantitative evaluation Methods 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 102100033601 Collagen alpha-1(I) chain Human genes 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 2
- 102100031457 Collagen alpha-1(V) chain Human genes 0.000 description 2
- 102100031519 Collagen alpha-1(VI) chain Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- 101000941708 Homo sapiens Collagen alpha-1(V) chain Proteins 0.000 description 2
- 101000941581 Homo sapiens Collagen alpha-1(VI) chain Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 235000020712 soy bean extract Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 101150100005 COL6A1 gene Proteins 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 101150035535 Col5a1 gene Proteins 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- 108010022514 Collagen Type V Proteins 0.000 description 1
- 102000012432 Collagen Type V Human genes 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 101000945357 Homo sapiens Collagen alpha-1(I) chain Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000011382 collagen catabolic process Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 230000010393 epithelial cell migration Effects 0.000 description 1
- 230000008556 epithelial cell proliferation Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 238000013424 sirius red staining Methods 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Abstract
본 발명은 금화규 추출물을 포함하는 피부 주름 및 탄력 개선용 조성물에 관한 것으로, 본 발명에 따른 금화규 추출물은 피부섬유아세포에서 콜라겐 생성을 촉진하는 효능이 우수하여, 피부 주름 및 탄력 개선에 유용한 효과가 있고, 금화규 뿌리 추출물과 무 추출물을 혼합하여 사용할 경우 피부 주름 및 탄력 개선에 상승효과가 있다.The present invention relates to a composition for improving skin wrinkles and elasticity comprising a Geumhwagyu extract, wherein the Geumhwagyu extract according to the present invention has an excellent effect of promoting collagen production in skin fibroblasts, and is useful for improving skin wrinkles and elasticity When using a mixture of Geumhwagyu root extract and radish extract, there is a synergistic effect in improving skin wrinkles and elasticity.
Description
본 발명은 금화규 추출물을 포함하는 피부 주름 및 탄력 개선용 조성물에 관한 것이다.The present invention relates to a composition for improving skin wrinkles and elasticity, comprising an extract of Geumhwagyu.
화장품은 우리 일상 생활과 깊이 관련되어 있으며 많은 사람들이 사용하고 있다. 인류의 문명이 발달하기 전 화장의 목적은 자연으로부터 신체를 보호하는 것이었으나, 과학과 문명의 발달과 더불어 화장의 목적은 신체를 청결하게 하고 아름답게 하며, 또한 노화를 지연시켜 아름답고 쾌적한 생활을 하게 하는 것으로 바뀌었다. 화장품의 기능은 청결과 미적 기능뿐만 아니라, 공해 물질과 스트레스, 자외선 등의 외적인 요인과 면역세포의 기능저하, 세포 활성의 저하 등의 내적 요인에 기인한 자유 라디칼(Free Radical), 활성산소, 과산화물 등에 의한 단백질, 핵산, 세포막 지질 파괴 등의 피부 노화의 원인을 제거하거나 억제하는 것이다. 또한, 소비자의 고기능 화장품에 대한 욕구를 충족시키기 위한 미백, 피부주름 개선 및 억제, 그리고 자외선 차단 기능을 갖는 화장품들이 계속해서 개발되고 있다. 그 중에서도 특히 주름 개선 및 억제 제품은 보다 젊음을 유지하려는 소비자의 많은 관심을 받는 대상이다.Cosmetics are deeply related to our daily life and are used by many people. Before the development of human civilization, the purpose of makeup was to protect the body from nature, but with the development of science and civilization, the purpose of makeup is to clean and beautify the body and delay aging to lead a beautiful and comfortable life. changed The functions of cosmetics are not only cleanliness and aesthetic functions, but also free radicals, free radicals, free radicals, and peroxides caused by external factors such as pollutants, stress, and ultraviolet rays, and internal factors such as decreased immune cell function and cell activity. It is to remove or inhibit the causes of skin aging, such as destruction of proteins, nucleic acids, and cell membrane lipids caused by such factors. In addition, cosmetics having whitening, skin wrinkle improvement and suppression, and UV blocking functions are continuously being developed to satisfy consumers' desire for high-functional cosmetics. Among them, anti-wrinkle and anti-wrinkle products are receiving a lot of attention from consumers who want to maintain their youthful appearance.
원래 노화 현상에 의한 주름은 피부 진피층의 콜라겐과 탄력 섬유의 소실로 인해 피부 표면에 생기는 골이라고 정의할 수 있다. 피부 주름은 진피층에 존재하는 콜라겐 교원섬유에 의해 결정되는데, 콜라겐 분자는 섬유 아세포에서 생성되어 진피층으로 분비된 후, 자동회합에 의해 콜라겐 섬유로 형성된다(Implant dentistry. 2002. 11(3):280-285). 콜라겐 섬유는 피부 진피층에서 피부의 기계적 견고성, 조직의 결합력, 세포와의 부착 및 세포분화 등에 관여한다 (Journal of the American Academy of Dermatology, 2001, 17(4):610-613). 이러한 콜라겐이 내적 요인 및 외적 요인에 의해 생성이 감소하거나 변형이 지속적으로 축적되게 되면 주름생성의 원인이 된다 (Clinics in geriatric medicine, 2001, 17(4):617-630).Wrinkles caused by aging can be defined as bones that occur on the skin surface due to the loss of collagen and elastic fibers in the dermal layer of the skin. Skin wrinkles are determined by collagen collagen fibers present in the dermal layer, and collagen molecules are produced in fibroblasts and secreted into the dermal layer, and then formed into collagen fibers by auto-association (Implant dentistry. 2002. 11(3):280). -285). Collagen fibers are involved in the mechanical firmness of the skin in the dermal layer of the skin, the binding force of tissues, adhesion to cells and cell differentiation, etc. (Journal of the American Academy of Dermatology, 2001, 17(4):610-613). When the production of such collagen is reduced by internal factors and external factors or deformation is continuously accumulated, it causes wrinkle formation (Clinics in geriatric medicine, 2001, 17(4):617-630).
콜라겐은 연령이 증가할수록, 그리고 자외선에 노출이 많이 될수록 양적 감소를 보인다. 콜라겐은 형태와 구조적 특징에 따라서 분류되는데 이들 중에서, 가장 특징이 잘 알려진 것은 타입 I, II, III 그리고 IV이다. 콜라겐 타입 I과 III는 진피층의 세포간질의 구성성분을 이루고 콜라겐 타입 IV는 DEJ (Dermal Epidermal Junction)의 주요 구성물질이 된다. DEJ는 피부의 표피층과 진피층 사이에 위치하여 두 층간의 물질 투과와 수송을 조절해주며 인접한 피부세포의 분화를 조절하며 피부의 견고성을 유지시켜준다. 피부의 주요 구조적 성분인 콜라겐과 엘라스틴은 자연적 또는 외부 자극에 의해 구조가 변성되거나 생합성량이 감소하게 되는데 이로 인해 피부 노화가 가속화된다. 또한 콜라게네이즈의 발현량과 활성 역시 피부 노화를 가속화시키는 주요 요인이다.Collagen shows a quantitative decrease with increasing age and exposure to UV rays. Collagen is classified according to its morphological and structural characteristics, of which the most well-known are types I, II, III and IV. Collagen types I and III constitute a component of the intercellular matrix of the dermal layer, and collagen type IV is a major component of DEJ (Dermal Epidermal Junction). DEJ is located between the epidermal and dermal layers of the skin and controls the permeation and transport of substances between the two layers, controls the differentiation of adjacent skin cells, and maintains the firmness of the skin. Collagen and elastin, which are the main structural components of the skin, are denatured or biosynthesized by natural or external stimuli, which accelerates skin aging. In addition, the expression level and activity of collagenase is also a major factor in accelerating skin aging.
콜라겐 합성 촉진물질로 기존에 레티노인산(retinoic acid), 표피성장인자(Epidermal growth factor: EGF), TGF(trans forming growth factor, 형질전환성장인자; Cardinale G. et al., Adv. Enzymol., 41, p. 425, 1974), 동물 태반 유래의 단백질(JP8-231370), 베툴린산(betulinic acid(JP8-208424)), 클로렐라 추출물 등이 알려져 있다. 특히 표피성장인자는 상피세포, 내피세포 및 섬유아세포 세포증식의 강력한 촉진제로 작용하며, 상피세포 결손 시 상피세포의 이동과 증식을 촉진시키기 때문에 상처치유 효과가 우수하다. 또한 레티놀은 콜라겐 합성과 분해억제에 매우 효과적으로 피부주름 개선 효과는 미국 특허 제4,603,146호 및 제4,877,805호 등에 명시되어 있다. 그러나 레티노인산의 경우 불안정하고, 피부 적용 시 자극, 발적 등의 안전성 문제로 사용량의 제한이 있으며, 클로렐라 추출물 등은 효과가 미미하여 실질적으로 피부의 콜라겐 합성을 촉진하여 피부 기능 개선 효과를 기대할 수 없다. 따라서, 생체에 안전하고 기존의 콜라겐 합성능 촉진 물질보다 효과가 높은 새로운 콜라겐 합성 촉진제의 개발이 절실히 요망되고 있다.As a collagen synthesis promoting material, retinoic acid, epidermal growth factor (EGF), trans forming growth factor (TGF); Cardinale G. et al., Adv. Enzymol., 41, p. 425, 1974), an animal placental-derived protein (JP8-231370), betulinic acid (JP8-208424), chlorella extract, and the like are known. In particular, epidermal growth factor acts as a strong promoter of epithelial cell, endothelial and fibroblast cell proliferation, and has excellent wound healing effect because it promotes epithelial cell migration and proliferation in case of epithelial cell defect. In addition, retinol is very effective in inhibiting collagen synthesis and degradation, and the effect of improving skin wrinkles is specified in US Patent Nos. 4,603,146 and 4,877,805. However, in the case of retinoic acid, it is unstable, and when applied to the skin, there is a limit on the amount of use due to safety problems such as irritation and redness, and chlorella extract, etc., have insignificant effect, so it can not be expected to improve skin function by actually promoting collagen synthesis in the skin. Therefore, there is an urgent need to develop a new collagen synthesis promoter that is safe for the living body and has a higher effect than the existing collagen synthesis promoting material.
한편, 금화규(Hibiseu Smanihot L.)는 진귀한 약용식물로 일년생 초본식물이며 일명 야생부용이라고도 불리워진다. 금화규의 꽃과 잎은 물론 꽃대와 뿌리는 해열, 해독, 항염증, 진통 효과 등 다양한 악성 통증 치료에 이용된다고 한다. 또한 천연 식물성 에스트로겐이 풍부하여 갱년기 증후군을 감소시키거나 연장하는데 도움을 주는 것으로 알려져 있다.On the other hand, Geumhwagyu ( Hibiseu Smanihot L. ) is a rare medicinal plant, an annual herbaceous plant, also called wild bouillon. It is said that the flowers and leaves of Geumhwagyu, as well as the flower stalks and roots, are used to treat various malignant pains, such as antipyretic, detoxifying, anti-inflammatory, and analgesic effects. It is also rich in natural phytoestrogens, which are known to help reduce or prolong menopause syndrome.
그러나, 현재까지 금화규의 콜라겐 생성 증대 효능에 관해 연구된 바는 없다.However, to date, there has been no study on the collagen production enhancing effect of Geumhwagyu.
본 발명의 목적은 피부 주름 개선용 화장료 조성물을 제공하는 것이다.It is an object of the present invention to provide a cosmetic composition for improving skin wrinkles.
본 발명의 목적은 피부 탄력 개선용 화장료 조성물을 제공하는 것이다.An object of the present invention is to provide a cosmetic composition for improving skin elasticity.
본 발명의 목적은 피부 주름 개선용 건강식품 조성물을 제공하는 것이다.An object of the present invention is to provide a health food composition for improving skin wrinkles.
본 발명의 목적은 피부 탄력 개선용 건강식품 조성물을 제공하는 것이다.An object of the present invention is to provide a health food composition for improving skin elasticity.
본 발명의 목적은 피부 주름 개선용 건강기능식품 조성물을 제공하는 것이다.It is an object of the present invention to provide a health functional food composition for improving skin wrinkles.
본 발명의 목적은 피부 탄력 개선용 건강기능식품 조성물을 제공하는 것이다.An object of the present invention is to provide a health functional food composition for improving skin elasticity.
상기 목적을 달성하기 위하여,In order to achieve the above object,
본 발명은 금화규(Hibiseu Smanihot L.) 추출물을 포함하는 피부 주름 개선용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for improving skin wrinkles comprising an extract of Geumhwagyu ( Hibiseu Smanihot L. ).
본 발명은 금화규(Hibiseu Smanihot L.) 추출물을 포함하는 피부 탄력 개선용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for improving skin elasticity comprising an extract of Geumhwagyu ( Hibiseu Smanihot L. ).
본 발명은 금화규(Hibiseu Smanihot L.) 추출물을 포함하는 피부 주름 개선용 건강식품 조성물을 제공한다.The present invention provides a health food composition for improving skin wrinkles comprising an extract of Geumhwagyu ( Hibiseu Smanihot L. ).
본 발명은 금화규(Hibiseu Smanihot L.) 추출물을 포함하는 피부 탄력 개선용 건강식품 조성물을 제공한다.The present invention provides a health food composition for improving skin elasticity comprising an extract of Geumhwagyu ( Hibiseu Smanihot L. ).
본 발명은 금화규(Hibiseu Smanihot L.) 추출물을 포함하는 피부 주름 개선용 건강기능식품 조성물을 제공한다.The present invention provides a health functional food composition for improving skin wrinkles comprising an extract of Geumhwagyu ( Hibiseu Smanihot L. ).
본 발명은 금화규(Hibiseu Smanihot L.) 추출물을 포함하는 피부 탄력 개선용 건강기능식품 조성물을 제공한다.The present invention provides a health functional food composition for improving skin elasticity comprising an extract of Geumhwagyu ( Hibiseu Smanihot L. ).
본 발명에 따른 조성물에 있어서, 상기 금화규 추출물은 추출용매로 물, 탄소수 1 내지 4의 저급알코올, 부틸렌글리콜, 프로필렌글리콜, 글리세린, 헥산, 메틸렌클로라이드, 에틸아세테이트, n-부탄올 등을 단독으로 또는 2종 이상 혼합하여 사용할 수 있다. 바람직하게는, 추출용매로 에탄올을 100%농도로 사용하거나 다양한 농도의 에탄올 수용액으로 희석하여 사용할 수 있다.In the composition according to the present invention, the Geumhwagyu extract is water, lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin, hexane, methylene chloride, ethyl acetate, n-butanol, etc. alone as an extraction solvent Or two or more types may be mixed and used. Preferably, ethanol may be used as an extraction solvent at a concentration of 100% or diluted with an aqueous ethanol solution of various concentrations.
본 발명에 따른 금화규(Hibiseu Smanihot L.) 추출물은 피부섬유아세포에서 콜라겐 생성을 촉진하는 효능이 우수하여, 피부 주름 및 탄력 개선에 유용한 효과가 있고, 금화규 뿌리 추출물과 무 추출물을 혼합하여 사용할 경우 피부 주름 및 탄력 개선에 상승효과가 있다.Geumhwagyu ( Hibiseu Smanihot L. ) extract according to the present invention has an excellent effect of promoting collagen production in skin fibroblasts, and has a useful effect in improving skin wrinkles and elasticity, and can be used by mixing the Geumhwagyu root extract and radish extract It has a synergistic effect in improving skin wrinkles and elasticity.
도 1은 금화규 추출물의 추출부위, 추출용매 및 처리농도에 따른 인간 피부섬유아세포(Hs68 cell)에서의 세포독성을 평가한 결과이다.
도 2는 금화규 추출물 처리에 따른 인간 피부섬유아세포(Hs68 cell)에서의 콜라겐 생성 관련 유전자 발현량을 real-time PCR을 통해 정량평가한 결과이다(****p<0.0001, ***p<0.0005, **p<0.005, *p<0.05).
도 3은 금화규 추출물 처리에 따른 인간 피부섬유아세포(Hs68 cell)에서의 콜라겐 분해 단백질(MMP1, MMP14) 발현량을 real-time PCR을 통해 정량평가한 결과이다(****p<0.0001, ***p<0.0005, **p<0.005, *p<0.05).
도 4 (A)는 금화규 추출물 처리에 따른 인간 피부섬유아세포(Hs68 cell)에서의 콜라겐 생성량을 평가한 결과이다(*p<0.05).
도 4 (B)는 금화규 추출물 처리에 따른 인간 피부섬유아세포(Hs68 cell)에서 COL1A1 유전자의 발현량을 western blotting 기법으로 확인한 결과이다.
도 5는 금화규 뿌리 및 무 혼합 추출물 처리에 따른 인간 피부섬유아세포(Hs68 cell)에서 COL1A1 유전자의 발현량을 western blotting 기법으로 확인한 결과이다.1 is a result of evaluating the cytotoxicity in human skin fibroblasts (Hs68 cell) according to the extraction site, extraction solvent, and treatment concentration of a Geumhwagyu extract.
2 is a result of quantitative evaluation of collagen production-related gene expression in human skin fibroblasts (Hs68 cells) according to the treatment with Geumhwagyu extract through real-time PCR (****p<0.0001, ***p <0.0005, **p<0.005, *p<0.05).
3 is a result of quantitative evaluation through real-time PCR of the expression levels of collagen-degrading proteins (MMP1, MMP14) in human skin fibroblasts (Hs68 cells) according to the treatment with Geumhwagyu extract (****p<0.0001, ***p<0.0005, **p<0.005, *p<0.05).
Figure 4 (A) is a result of evaluating the amount of collagen production in human dermal fibroblasts (Hs68 cells) according to the treatment with Geumhwagyu extract (*p<0.05).
Figure 4 (B) is the result of confirming the expression level of the COL1A1 gene in human skin fibroblasts (Hs68 cells) according to the treatment with Geumhwagyu extract by western blotting.
5 is a result of confirming the expression level of the COL1A1 gene in human skin fibroblasts (Hs68 cells) according to the treatment of Geumhwagyu root and radish extract by western blotting.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
화장료 조성물cosmetic composition
본 발명은 유효물질을 포함하는 화장료 조성물을 제공한다.The present invention provides a cosmetic composition comprising an active substance.
상기 화장료 조성물은, 예를 들면 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태, 크림, 스킨, 로션, 파우더, 연고, 스프레이 또는 콘실 스틱의 형태로 제공될 수 있다. 또한, 포말(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The cosmetic composition is, for example, a solution, a gel, a solid or kneaded anhydrous product, an emulsion obtained by dispersing an oil phase in an aqueous phase, a suspension, a microemulsion, a microcapsule, a microgranule or an ionic (liposome), a nonionic vesicle dispersant It may be provided in the form of a cream, toner, lotion, powder, ointment, spray or concealer stick. In addition, it may be prepared in the form of a foam or an aerosol composition further containing a compressed propellant.
또한, 상기 화장료 조성물은 본 발명의 유효물질에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.In addition, the cosmetic composition comprises a fatty substance, an organic solvent, a solubilizer, a thickening agent and a gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant, Commonly used in water, ionic or nonionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic actives, lipid vesicles or cosmetics It may contain adjuvants commonly used in the cosmetic field, such as any other ingredients that are used.
본 발명의 유효물질을 함유하는 화장료 조성물에 있어서, 통상적으로 함유되는 화장료 조성물에 본 발명의 유효물질이 0.1 내지 50 중량%, 바람직하게는 1 내지 10 중량%의 양으로 첨가될 수 있다.In the cosmetic composition containing the active substance of the present invention, the active substance of the present invention may be added in an amount of 0.1 to 50% by weight, preferably 1 to 10% by weight, to the cosmetic composition usually contained.
본 발명의 유효물질을 피부 외용제로 사용하는 경우, 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 피부용 외용제에 통상적으로 사용되는 임의의 다른 성분과 같은 피부 과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 또한, 상기 성분들은 피부 과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.When the active substance of the present invention is used as an external preparation for skin, additionally, a fatty substance, an organic solvent, a solubilizer, a thickening agent and a gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant , water, ionic or non-ionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or for external use on the skin It may contain adjuvants commonly used in the field of dermatology, such as any other ingredients used as a skin care product. In addition, the above ingredients may be introduced in an amount generally used in the field of dermatology.
건강식품 및 건강기능성식품 조성물Health food and health functional food composition
식품의 종류에는 특별한 제한은 없다. 본 발명의 유효물질을 첨가할 수 있는 식품의 예로는 드링크제, 육류, 소시지, 빵, 비스킷, 떡, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 알코올 음료 및 비타민 복합제, 유제품 및 유가공 제품 등이 있으며, 통상적인 의미에서의 건강식품 및 건강기능성식품을 모두 포함한다.There are no special restrictions on the type of food. Examples of foods to which the active substance of the present invention can be added include drinks, meat, sausage, bread, biscuits, rice cakes, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products including ice cream, There are various soups, beverages, alcoholic beverages and vitamin complexes, dairy products and processed dairy products, and includes all health food and health functional food in the ordinary sense.
본 발명에 따른 유효물질을 함유하는 건강식품 및 건강기능성식품 조성물은 식품에 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효물질의 혼합량은 그의 사용 목적(예방 또는 개선용)에 따라 적합하게 결정될 수 있다. 일반적으로, 건강식품 및 건강기능성식품 중의 상기 조성물의 양은 전체 식품 중량의 0.1 내지 90 중량부로 가할 수 있다. 그러나 건강 유지를 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로도 사용될 수 있다.The health food and health functional food composition containing the active substance according to the present invention may be added to food as it is or used together with other food or food ingredients, and may be appropriately used according to a conventional method. The mixing amount of the active substance may be appropriately determined depending on the purpose of its use (for prevention or improvement). In general, the amount of the composition in health food and health functional food may be added in an amount of 0.1 to 90 parts by weight based on the total weight of the food. However, in the case of long-term intake for health maintenance or health control, the above amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount above the above range.
본 발명의 건강식품 및 건강기능성식품 조성물은 지시된 비율로 필수 성분으로서 본 발명 유효물질을 함유하는 외에는 다른 성분에는 특별한 제한이 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트라이톨 등의 당알코올이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 건강기능성 식품 조성물 100 당 일반적으로 약 1 내지 20 g, 바람직하게는 약 5 내지 12 g이다.The health food and health functional food composition of the present invention is not particularly limited in other ingredients except that it contains the active substance of the present invention as an essential ingredient in the indicated ratio, and various flavoring agents or natural carbohydrates are added as additional ingredients like conventional beverages. may contain. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; disaccharides such as maltose, sucrose and the like; and polysaccharides such as conventional sugars such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those described above, natural flavoring agents (taumatin, stevia extract (for example, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. The proportion of the natural carbohydrate is generally about 1 to 20 g, preferably about 5 to 12 g, per 100 nutraceuticals of the present invention.
상기 외에 본 발명의 유효물질을 함유하는 건강식품 및 건강기능성식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 건강식품 및 건강기능성식품 조성물은 천연 과일쥬스 및 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다.In addition to the above, health food and health functional food composition containing the active substance of the present invention are various nutrients, vitamins, minerals (electrolytes), synthetic flavoring agents and flavoring agents such as natural flavoring agents, coloring agents and thickening agents (cheese, chocolate, etc.) ), pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like. In addition, the health food and health functional food composition of the present invention may contain natural fruit juice, fruit juice, and fruit for the production of a vegetable drink.
이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 유효물질을 함유하는 건강식품 및 건강기능성식품 조성물 100 중량부 당 0.1 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다.These components may be used independently or in combination. The proportion of these additives is not so important, but is generally selected in the range of 0.1 to about 20 parts by weight per 100 parts by weight of the health food and health functional food composition containing the active substance of the present invention.
이하, 본 발명을 하기의 실시예에 의하여 더욱 상세하게 설명한다. 단, 하기의 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기의 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the following examples only illustrate the present invention, and the content of the present invention is not limited by the following examples.
<실시예 1> 금화규(<Example 1> Geumhwagyu ( Hibiseu Smanihot L.Hibiseu Smanihot L. ) 추출물의 준비) preparation of extracts
국내에서 재배한 금화규를 뿌리(roots), 대(stems), 잎(leaves) 부위별로 건조한 후 100% 에탄올 또는 70% 에탄올을 추출용매로 하여 추출하였다. 금화규 잎의 경우 70% 에탄올로 추출시 수율이 매우 낮아 100% 에탄올로 추출을 실시하였다. 상기에서 얻은 추출물은 동결건조한 다음 DMSO 용매에 녹여 다양한 농도(0.01, 0.1, 1, 10, 100 ㎍/mL)의 시료로 준비하여 다음의 실험에 사용하였다.Geumhwagyu grown in Korea was dried by roots, stems, and leaves, and then extracted with 100% ethanol or 70% ethanol as an extraction solvent. In the case of Geumhwagyu leaves, the yield was very low when extracted with 70% ethanol, and extraction was performed with 100% ethanol. The extract obtained above was freeze-dried and then dissolved in DMSO solvent to prepare samples of various concentrations (0.01, 0.1, 1, 10, 100 μg/mL) and used in the following experiments.
<실험예 1> 금화규(<Experimental Example 1> Geumhwagyu ( Hibiseu Smanihot L.Hibiseu Smanihot L. ) 추출물의 세포독성 평가) evaluation of the cytotoxicity of the extract
인간 피부섬유아세포(Hs68 cell)에 상기 실시예 1에서 준비한 시료를 농도별로 24시간 처리 후 CCK-8 assy를 통해 추출물의 피부세포에서의 독성을 평가하였고, 그 결과를 도 1에 나타내었다. 여기서, 대조군(Cont)은 시료를 처리하지 않았다.Human skin fibroblasts (Hs68 cells) were treated with the sample prepared in Example 1 for each concentration for 24 hours, and then toxicity of the extract was evaluated in skin cells through CCK-8 assy, and the results are shown in FIG. 1 . Here, the control group (Cont) was not treated with the sample.
도 1은 금화규 추출물의 추출부위, 추출용매 및 처리농도에 따른 인간 피부섬유아세포(Hs68 cell)에서의 세포독성을 평가한 결과이다. 1 is a result of evaluating the cytotoxicity in human skin fibroblasts (Hs68 cells) according to the extraction site, extraction solvent and treatment concentration of Geumhwagyu extract.
도 1에 나타난 바와 같이, 모든 시료에서 세포독성이 나타나지 않아, 금화규 추출물은 피부에 안전한 것으로 확인하였다.As shown in FIG. 1 , no cytotoxicity was observed in any of the samples, and it was confirmed that the Geumhwagyu extract was safe for the skin.
<실험예 2> 금화규 추출물이 콜라겐 유전자 발현에 미치는 영향 평가<Experimental Example 2> Evaluation of the effect of Geumhwagyu extract on collagen gene expression
피부 콜라겐에서 가장 많은 부분을 차지하고 이는 COL1A1(Collagen, type I, alpha 1) 유전자와 그 외에 COL5A1(Collagen, type Ⅴ, alpha 1) 유전자 그리고 COL6A1(Collagen, type Ⅵ, alpha 1) 유전자 발현량 증대 효과를 알아보기 위하여 실험을 하였다.It occupies the largest portion of skin collagen, which increases the expression level of COL1A1 (Collagen, type I, alpha 1) gene, COL5A1 (Collagen, type V, alpha 1) gene, and COL6A1 (Collagen, type VI, alpha 1) gene expression. An experiment was conducted to find out.
구체적으로, 상기 실시예 1에서 준비한 금화규 추출물 시료 10 ㎍/mL을 인간 피부섬유아세포(Hs68 cell)에 처리한 24시간 후 콜라겐 유전자들의 발현에 미치는 영향을 real-time PCR을 통해 확인하였고, 그 결과를 도 2에 나타내었다. 여기서, 대조군(Cont)은 시료를 처리하지 않았다.Specifically, the effect of 10 μg/mL of the Geumhwagyu extract sample prepared in Example 1 on the expression of collagen genes after 24 hours of treatment with human skin fibroblasts (Hs68 cells) was confirmed through real-time PCR, and the The results are shown in FIG. 2 . Here, the control group (Cont) was not treated with the sample.
도 2는 금화규 추출물 처리에 따른 인간 피부섬유아세포(Hs68 cell)에서의 콜라겐 생성 관련 유전자 발현량을 real-time PCR을 통해 정량평가한 결과이다(****p<0.0001, ***p<0.0005, **p<0.005, *p<0.05).2 is a result of quantitative evaluation of collagen production-related gene expression in human skin fibroblasts (Hs68 cells) according to the treatment with Geumhwagyu extract through real-time PCR (****p<0.0001, ***p <0.0005, **p<0.005, *p<0.05).
도 2 (A)에 나타난 바와 같이, 100% EtOH로 추출된 금화규 뿌리(root), 대(stem), 70% EtOH로 추출된 금화규 뿌리 추출물의 경우 피부 콜라겐에서 가장 많은 부분을 차지하고 이는 COL1A1의 유전자 발현을 대조군 대비 2배이상 증가시킴을 확인하였다.As shown in Figure 2 (A), in the case of Geumhwagyu root and stem extracted with 100% EtOH, and Geumhwagyu root extract extracted with 70% EtOH, it occupies the most portion in skin collagen, which is COL1A1 It was confirmed that the gene expression of the control group was increased more than 2 times compared to the control group.
도 2 (B)에 나타난 바와 같이, 100% EtOH로 추출된 금화규 뿌리, 70% EtOH로 추출된 금화규 뿌리 추출물의 경우 COL5A1의 유전자 발현을 대조군 대비 미세하게 증가시키는 것으로 보이나 통계적으로는 유의미하지 않은 것으로 나타나, 모든 금화규 부위별로 COL5A1 유전자의 발현에는 크게 영향을 미치지 않는 것으로 나타났다.As shown in FIG. 2 (B), the Geumhwagyu root extract extracted with 100% EtOH and the Keumhwagyu root extract extracted with 70% EtOH seemed to slightly increase the gene expression of COL5A1 compared to the control group, but it was not statistically significant. It was found that there was no significant effect on the expression of the COL5A1 gene by all regions of Keumhwagyu.
도 2 (C)에 나타난 바와 같이, 모든 금화규의 부위별 추출물이 COL6A1 유전자의 발현을 증가시킴을 확인하였다.As shown in Fig. 2 (C), it was confirmed that all extracts of each part of Geumhwagyu increased the expression of the COL6A1 gene.
상기 도 2의 결과를 종합하여 보면, 100% EtOH 용매로 추출된 금화규 뿌리, 대 추출물, 그리고 70% EtOH 용매로 추출된 금화규 뿌리 추출물이 콜라겐 합성을 촉진할 것으로 예상된다.Combining the results of FIG. 2 , it is expected that the Geumhwagyu root extract extracted with 100% EtOH solvent, the large extract, and the Geumhwagyu root extract extracted with the 70% EtOH solvent will promote collagen synthesis.
<실험예 3> 금화규 추출물의 MMP 단백질 발현에 미치는 영향 평가<Experimental Example 3> Evaluation of the effect of Geumhwagyu extract on MMP protein expression
MMP(matrix metalloproteinase) 단백질은 콜라겐을 분해하는 단백질로서 금화규 추출물이 MMP 유전자 발현량 감소에 미치는 영향을 알아보기 위하여 실험을 하였다.MMP (matrix metalloproteinase) protein is a protein that decomposes collagen, and an experiment was conducted to investigate the effect of Geumhwagyu extract on the reduction of MMP gene expression.
구체적으로, 상기 실시예 1에서 준비한 금화규 추출물 시료 10 ㎍/mL을 인간 피부섬유아세포(Hs68 cell)에 처리한 24시간 후 MMP1, MMP14 유전자들의 발현에 미치는 영향을 real-time PCR을 통해 확인하였고, 그 결과를 도 3에 나타내었다. 여기서, 대조군(Cont)은 시료를 처리하지 않았다.Specifically, the effect on the expression of MMP1 and MMP14 genes after 24 hours of treatment with 10 μg/mL of the Geumhwagyu extract sample prepared in Example 1 in human skin fibroblasts (Hs68 cells) was confirmed through real-time PCR. , the results are shown in FIG. 3 . Here, the control group (Cont) was not treated with the sample.
도 3은 금화규 추출물 처리에 따른 인간 피부섬유아세포(Hs68 cell)에서의 콜라겐 분해 단백질(MMP1, MMP14) 발현량을 real-time PCR을 통해 정량평가한 결과이다(****p<0.0001, ***p<0.0005, **p<0.005, *p<0.05).3 is a result of quantitative evaluation through real-time PCR of the expression levels of collagen-degrading proteins (MMP1, MMP14) in human skin fibroblasts (Hs68 cells) according to the treatment with Geumhwagyu extract (****p<0.0001, ***p<0.0005, **p<0.005, *p<0.05).
도 3 (A)에 나타난 바와 같이, 100% EtOH 뿌리, 대, 70% EtOH 뿌리 추출물은 MMP1 단백질의 발현량이 유의미하게 감소하는 반면에, 100% EtOH 잎 추출물의 경우 MMP1 단백질의 발현량이 반대로 증가하는 것을 확인하였다.As shown in Figure 3 (A), 100% EtOH root, large, 70% EtOH root extract significantly decreased the expression level of MMP1 protein, whereas in the case of 100% EtOH leaf extract, the expression level of MMP1 protein increased inversely. confirmed that.
도 3 (B)에 나타난 바와 같이, 70% EtOH로 추출된 금화규 뿌리 추출물의 경우 MMP14 단백질의 발현량이 증가하여 부정적인 결과가 나타났으나, 나머지 모든 실험군에서는 MMP14 단백질의 발현에 통계적으로 유의미한 차이가 나타나지 않았다.As shown in FIG. 3 (B), in the case of Geumhwagyu root extract extracted with 70% EtOH, the expression level of MMP14 protein increased, resulting in negative results, but in all other experimental groups, there was a statistically significant difference in the expression of MMP14 protein. did not appear
상기 도 3의 결과를 종합하여 보면, 100% 용매로 추출된 금화규 뿌리, 대 추출물이 MMP1의 발현은 감소시키고, MMP14의 발현에는 영향을 주지 않으므로, 이 두 추출물이 콜라겐 분해를 저해할 것으로 예상된다.3, it is expected that the 100% solvent-extracted Geumhwagyu root and large extracts reduce the expression of MMP1 and do not affect the expression of MMP14, so these two extracts are expected to inhibit collagen degradation. do.
<실험예 4> 금화규 추출물의 콜라겐 합성 증가량 평가<Experimental Example 4> Evaluation of collagen synthesis increase in Geumhwagyu extract
금화규 추출물이 인간 피부섬유아세포에서 실제로 콜라겐의 생성량 증가시키는지 알아보기 위하여 실험을 하였다.An experiment was conducted to find out whether Geumhwagyu extract actually increases collagen production in human skin fibroblasts.
구체적으로, 상기 실시예 1에서 준비한 금화규 추출물 시료 10 ㎍/mL을 인간 피부섬유아세포(Hs68 cell)에 처리한 48시간 후 soluble 콜라겐의 양을 Sirius red 염색법을 이용하여 측정하였고, 그 결과를 도 4 (A)에 나타내었다. 또한, 상기 실시예 1에서 준비한 금화규 추출물 시료 10 ㎍/mL을 인간 피부섬유아세포(Hs68 cell)에 처리한 48시간 후 COL1A1 유전자의 발현량을 western blotting 기법으로 확인한 결과를 도 4 (B)에 나타내었다.Specifically, the amount of soluble collagen was measured using Sirius red staining method after 48 hours of treatment with 10 μg/mL of the Geumhwagyu extract sample prepared in Example 1 in human skin fibroblasts (Hs68 cells), and the results are shown in Fig. 4 (A) shows. In addition, the result of confirming the expression level of the COL1A1 gene by western blotting method after 48 hours of treatment with 10 μg/mL of the Geumhwagyu extract sample prepared in Example 1 in human skin fibroblasts (Hs68 cells) is shown in FIG. 4 (B). indicated.
도 4 (A)는 금화규 추출물 처리에 따른 인간 피부섬유아세포(Hs68 cell)에서의 콜라겐 생성량을 평가한 결과이다(*p<0.05).Figure 4 (A) is a result of evaluating the amount of collagen production in human dermal fibroblasts (Hs68 cells) according to the treatment with Geumhwagyu extract (*p<0.05).
도 4 (B)는 금화규 추출물 처리에 따른 인간 피부섬유아세포(Hs68 cell)에서 COL1A1 유전자의 발현량을 western blotting 기법으로 확인한 결과이다.Figure 4 (B) is the result of confirming the expression level of the COL1A1 gene in human dermal fibroblasts (Hs68 cells) according to the treatment with Geumhwagyu extract by western blotting.
도 4 (A)에 나타난 바와 같이, 100% EtOH로 추출된 금화규 뿌리, 대 두 추출물의 경우 대조군에 비해 soluble 콜라겐의 양을 약 3배 증가시킴을 확인하였다.As shown in FIG. 4 (A), it was confirmed that the amount of soluble collagen was increased by about 3 times compared to the control in the case of Geumhwagyu root and soybean extract extracted with 100% EtOH.
도 4 (B)에 나타난 바와 같이, 100% EtOH로 추출된 금화규 뿌리, 대 두 추출물의 경우 대조군에 비해 COL1A1 유전자 발현량이 증가하는 것을 확인하였다.As shown in FIG. 4 (B), it was confirmed that the COL1A1 gene expression level was increased in the case of Geumhwagyu root and soybean extracts extracted with 100% EtOH compared to the control group.
도 4의 결과를 종합해 보면, 100% EtOH로 추출된 금화규 뿌리, 대 추출물은 COL1A1 유전자의 발현을 증가시킴과 동시에 전체적인 soluble 콜라겐 합성을 증가시킴을 확인할 수 있었다.Combining the results of Figure 4, it was confirmed that the Geumhwagyu root and large extract extracted with 100% EtOH increased the COL1A1 gene expression and at the same time increased the overall soluble collagen synthesis.
<실험예 5> 금화규 뿌리 및 무 혼합 추출물의 콜라겐 합성 상승효과 평가<Experimental Example 5> Evaluation of collagen synthesis synergistic effect of Geumhwagyu root and radish mixed extract
국내산 유기농 무(Raphanus sativus var. hortensis for. Acanthiformis MAKINO) 및 금화규(Hibiseu Smanihot L.) 뿌리를 건조 후 각각 100% 에탄올 (EtOH) 용매로 추출한 다음, 동결건조된 각각의 추출물을 DMSO 용매에 녹인 후 도 5에 명시된 중량 비율로 혼합 추출물 시료를 준비하였다.After drying domestic organic radish ( Raphanus sativus var. hortensis for. Acanthiformis MAKINO ) and Geumhwagyu ( Hibiseu Smanihot L. ) roots, each was extracted with 100% ethanol (EtOH) solvent, and then each lyophilized extract was dissolved in DMSO solvent. After that, a mixed extract sample was prepared at the weight ratio specified in FIG. 5 .
이렇게 준비된 혼합 추출물 용액을 인간 피부섬유아세포 Hs68 세포에 10ug/ml 농도로 24시간 처리 후 COL1A1 유전자 발현 양상을 확인하였고, 그 결과를 도 5에 나타내었다. The COL1A1 gene expression pattern was confirmed after treatment with the thus prepared mixed extract solution in human skin fibroblast Hs68 cells at a concentration of 10ug/ml for 24 hours, and the results are shown in FIG. 5 .
도 5는 금화규 뿌리 및 무 혼합 추출물 처리에 따른 인간 피부섬유아세포(Hs68 cell)에서 COL1A1 유전자의 발현량을 western blotting 기법으로 확인한 결과이다.5 is a result of confirming the expression level of the COL1A1 gene in human dermal fibroblasts (Hs68 cells) according to the treatment of Geumhwagyu root and radish extract by western blotting.
도 5에 나타난 바와 같이, 무 추출물 및 금화규 뿌리 추출물을 80:20 중량비로 혼합한 시료에서만 선택적으로 유의미한 상승효과가 관찰되었고, 다른 비율로 혼합한 시료에서는 상승효과가 관찰되지 않았다.As shown in FIG. 5 , a significant synergistic effect was selectively observed only in the sample in which the radish extract and the Geumhwagyu root extract were mixed in an 80:20 weight ratio, and no synergistic effect was observed in the sample mixed in different ratios.
한편, 특이하게도 금화규의 뿌리 이외의 다른 부위 추출물과 무 추출물의 혼합 추출물에서는 이러한 상승효과가 관찰되지 않았는데, 이는 금화규 뿌리 부위의 특정 성분과 무의 특정 성분이 상승효과를 내는 것으로 예상된다.On the other hand, unusually, such a synergistic effect was not observed in the mixed extract of the radish extract and the extract from other parts than the root of Geumhwagyu, which is expected to produce a synergistic effect between the specific component of the root of Geumhwagyu and the specific component of the radish.
화장료의 제조예Preparation example of cosmetics
본 발명에 따른 유효물질은 목적에 따라 여러 형태의 화장료로 제조 가능하다. 하기는 본 발명에 따른 유효물질을 활성성분으로 함유시킨 몇몇 화장료의 제조방법을 예시한 것으로 본 발명이 이에 한정되는 것은 아니다.The active substance according to the present invention can be manufactured into various types of cosmetics depending on the purpose. The following exemplifies the manufacturing method of several cosmetics containing the active ingredient according to the present invention as an active ingredient, but the present invention is not limited thereto.
<화장료 제조예 1> 유연 화장수의 제조<Cosmeceutical Preparation Example 1> Preparation of softened lotion
유효물질 10.0 중량부10.0 parts by weight of active substance
1,3-부틸렌글리콜 1.00 중량부1,3-butylene glycol 1.00 parts by weight
디소듐이디티에이 0.05 중량부Disodium EDTA 0.05 parts by weight
알란토인 0.10 중량부Allantoin 0.10 parts by weight
디포타슘글리시리제이트 0.05 중량부Dipotassium glycyrrhizate 0.05 parts by weight
시트르산 0.01 중량부citric acid 0.01 parts by weight
소듐시트레이트 0.02 중량부Sodium citrate 0.02 parts by weight
글리세레스-26 1.00 중량부Glycereth-26 1.00 parts by weight
알부틴 2.00 중량부Arbutin 2.00 parts by weight
하이드로제네이티드캐스터오일 1.00 중량부1.00 parts by weight of hydrogenated castor oil
에탄올 30.0 중량부Ethanol 30.0 parts by weight
보존제 미량preservative trace
착색제 미량trace amount of colorant
착향제 미량Trace amount of flavoring agent
정제수 잔량Purified water remaining
<화장료 제조예 2> 영양 크림의 제조<Cosmeceutical Preparation Example 2> Preparation of nourishing cream
유효물질 10.0 중량부10.0 parts by weight of active substance
1,3-부틸렌글리콜 7.00 중량부1,3-butylene glycol 7.00 parts by weight
글리세린 1.00 중량부1.00 parts by weight of glycerin
D-판테놀 0.10 중량부D-panthenol 0.10 parts by weight
식물 추출물 3.20 중량부3.20 parts by weight of plant extract
마그네슘알루미늄실리케이트 0.30 중량부0.30 parts by weight of magnesium aluminum silicate
PEG-40 스테아레이트 1.20 중량부PEG-40 stearate 1.20 parts by weight
스테아르산 2.00 중량부2.00 parts by weight of stearic acid
폴리소르베이트 60 1.50 중량부1.50 parts by weight of polysorbate 60
친유형글리세릴스테아레이트 2.00 중량부2.00 parts by weight of lipophilic glyceryl stearate
소르비탄세스퀴올리에이트 1.50 중량부1.50 parts by weight of sorbitan sesquioleate
세테아릴알코올 3.00 중량부3.00 parts by weight of cetearyl alcohol
미네랄오일 4.00 중량부4.00 parts by weight of mineral oil
스쿠알란 3.80 중량부3.80 parts by weight of squalane
카르릴릭/카프릭트리글리세라이드 2.80 중량부2.80 parts by weight of carlylic/capric triglyceride
식물성오일 1.80 중량부1.80 parts by weight of vegetable oil
디메치콘 0.40 중량부Dimethicone 0.40 parts by weight
디포슘글리시리제이트 미량Trace amount of dipotassium glycyrrhizate
알란토인 미량allantoin traces
소듐 히아루로네이트 미량Sodium Hyaluronate Trace
토코페릴아세테이트 적량Tocopheryl Acetate Appropriate amount
트리에탄올아민 적량Appropriate amount of triethanolamine
보존제 적량Appropriate amount of preservative
착향제 적량Appropriate amount of flavoring agent
정제수 잔량Purified water remaining
건강식품의 제조예Manufacturing example of health food
본 발명에 따른 유효물질은 목적에 따라 여러 형태의 건강식품으로 제조 가능하다. 하기는 본 발명에 따른 유효물질을 활성성분으로 함유시킨 몇몇 건강식품의 제조방법을 예시한 것으로 본 발명이 이에 한정되는 것은 아니다.The active substance according to the present invention can be manufactured into various types of health food depending on the purpose. The following exemplifies the manufacturing method of several health foods containing the active ingredient according to the present invention as an active ingredient, but the present invention is not limited thereto.
<건강식품 제조예 1> 유제품(dairy products)의 제조<Health food production example 1> Production of dairy products
본 발명의 유효물질 0.01-1 중량부를 우유에 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.0.01-1 parts by weight of the active substance of the present invention was added to milk, and various dairy products such as butter and ice cream were prepared using the milk.
<건강식품 제조예 2> 선식의 제조<Health food production example 2> Preparation of wire food
현미, 보리, 찹쌀, 율무를 공지의 방법으로 알파화시켜 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다. 검정콩, 검정깨, 들깨도 공지의 방법으로 쪄서 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다. 본 발명의 유효물질을 진공 농축기에서 감압농축하고 건조분말을 얻었다. 상기에서 제조한 곡물류, 종실류 및 유효물질의 건조분말을 다음의 비율로 배합하여 제조하였다.Brown rice, barley, glutinous rice, and barley radish were pregelatinized by a known method and dried, and then roasted and prepared as a powder having a particle size of 60 mesh with a grinder. Black soybeans, black sesame, and perilla were also steamed and dried by a known method, and then roasted and prepared into powder having a particle size of 60 mesh with a grinder. The active material of the present invention was concentrated under reduced pressure in a vacuum concentrator to obtain a dry powder. The above-prepared grains, seeds, and dry powders of active substances were prepared by blending them in the following ratios.
곡물류(현미 34 중량부, 율무 19 중량부, 보리 20 중량부),Grains (34 parts by weight of brown rice, 19 parts by weight of barley, 20 parts by weight of barley),
종실류(들깨 7 중량부, 검정콩 8 중량부, 검정깨 7 중량부),Seeds (7 parts by weight of perilla, 8 parts by weight of black beans, 7 parts by weight of black sesame),
유효물질 (2 중량부),active substance (2 parts by weight),
영지(1.5 중량부), 및Reishi (1.5 parts by weight), and
지황(1.5 중량부).Rehmannia (1.5 parts by weight).
건강기능식품의 제조예Manufacturing example of health functional food
본 발명에 따른 유효물질은 목적에 따라 여러 형태의 건강기능식품으로 제조 가능하다. 하기는 본 발명에 따른 유효물질을 활성성분으로 함유시킨 몇몇 건강기능식품의 제조방법을 예시한 것으로 본 발명이 이에 한정되는 것은 아니다.The active substance according to the present invention can be manufactured into various types of health functional food depending on the purpose. The following exemplifies the manufacturing method of several health functional foods containing the active ingredient according to the present invention as an active ingredient, but the present invention is not limited thereto.
<건강기능식품 제조예 1> 건강기능식품의 제조<Health functional food manufacturing example 1> Manufacture of health functional food
유효물질 100 mg100 mg of active substance
비타민 혼합물 적량appropriate amount of vitamin mixture
비타민 A 아세테이트 70 μgVitamin A
비타민 E 1.0 mgVitamin E 1.0 mg
비타민 B1 0.13 mgVitamin B1 0.13 mg
비타민 B2 0.15 mgVitamin B2 0.15 mg
비타민 B6 0.5 mg0.5 mg of vitamin B6
비타민 B12 0.2 μg0.2 μg of vitamin B12
비타민 C 10 mg
비오틴 10 μgBiotin 10 μg
니코틴산아미드 1.7 mgNicotinamide 1.7 mg
엽산 50 μg50 μg of folic acid
판토텐산 칼슘 0.5 mgCalcium pantothenate 0.5 mg
무기질 혼합물 적량Appropriate amount of inorganic mixture
황산제1철 1.75 mgferrous sulfate 1.75 mg
산화아연 0.82 mgZinc Oxide 0.82 mg
탄산마그네슘 25.3 mgMagnesium carbonate 25.3 mg
제1인산칼륨 15 mgPotassium monophosphate 15 mg
제2인산칼슘 55 mgDibasic calcium phosphate 55 mg
구연산칼륨 90 mgPotassium citrate 90 mg
탄산칼슘 100 mg100 mg calcium carbonate
염화마그네슘 24.8 mgMagnesium chloride 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강기능성 식품에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강기능성 식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강기능성 식품 조성물 제조에 사용할 수 있다.Although the composition ratio of the vitamin and mineral mixture is relatively suitable for health functional food in a preferred embodiment, the composition ratio may be arbitrarily modified, and the above ingredients are mixed according to a conventional health functional food manufacturing method. Then, the granules can be prepared and used in the preparation of a health functional food composition according to a conventional method.
<건강기능식품 제조예 2> 건강 기능 음료의 제조<Health functional food production example 2> Preparation of health functional beverage
유효물질 100 mg100 mg of active substance
구연산 100 mg100 mg citric acid
올리고당 100 mg100 mg of oligosaccharides
매실농축액 2 mg
타우린 100 mg
정제수를 가하여 전체 500 mLAdd purified water to total 500 mL
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간 동안 85℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 1 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강음료 조성물 제조에 사용한다. 상기 조성비는 비교적 기호 음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용 용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.After mixing the above ingredients according to a conventional health drink manufacturing method, stirring and heating at 85° C. for about 1 hour, the resulting solution is filtered and obtained in one sterilized container, sealed and sterilized, and then refrigerated. used in the manufacture of health beverage compositions of Although the composition ratio is prepared by mixing ingredients suitable for relatively favorite beverages in a preferred embodiment, the mixing ratio may be arbitrarily modified according to regional and national preferences such as demand class, demand country, and use purpose.
Claims (18)
무 추출물 80 중량부 기준 금화규 뿌리 추출물 20 중량부 포함하는 것을 특징으로 하는 피부 주름 개선용 화장료 조성물.
Geumhwagyu ( Hibiseu Smanihot L. ) root extract and radish ( Raphanus sativus var. hortensis for. acanthiformis MAKINO ) extract,
A cosmetic composition for improving skin wrinkles, comprising 20 parts by weight of the Geumhwagyu root extract based on 80 parts by weight of the radish extract.
상기 추출물은 물, 탄소수 1 내지 4의 저급알코올, 부틸렌글리콜, 프로필렌글리콜, 글리세린, 헥산, 메틸렌클로라이드, 에틸아세테이트 및 n-부탄올 중 1종 이상의 추출용매를 이용하여 수득된 것을 특징으로 하는, 피부 주름 개선용 화장료 조성물.
The method of claim 1,
The extract is water, a lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin, hexane, methylene chloride, ethyl acetate and n-butanol, characterized in that obtained using one or more extraction solvents, skin A cosmetic composition for improving wrinkles.
무 추출물 80 중량부 기준 금화규 뿌리 추출물 20 중량부 포함하는 것을 특징으로 하는 피부 탄력 개선용 화장료 조성물.
Geumhwagyu ( Hibiseu Smanihot L. ) root extract and radish ( Raphanus sativus var. hortensis for. acanthiformis MAKINO ) extract,
A cosmetic composition for improving skin elasticity, comprising 20 parts by weight of the Geumhwagyu root extract based on 80 parts by weight of the radish extract.
상기 추출물은 물, 탄소수 1 내지 4의 저급알코올, 부틸렌글리콜, 프로필렌글리콜, 글리세린, 헥산, 메틸렌클로라이드, 에틸아세테이트 및 n-부탄올 중 1종 이상의 추출용매를 이용하여 수득된 것을 특징으로 하는, 피부 탄력 개선용 화장료 조성물.
5. The method of claim 4,
The extract is water, a lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin, hexane, methylene chloride, ethyl acetate and n-butanol, characterized in that obtained using one or more extraction solvents, skin A cosmetic composition for improving elasticity.
무 추출물 80 중량부 기준 금화규 뿌리 추출물 20 중량부 포함하는 것을 특징으로 하는 피부 주름 개선용 건강식품 조성물.
Geumhwagyu ( Hibiseu Smanihot L. ) root extract and radish ( Raphanus sativus var. hortensis for. acanthiformis MAKINO ) extract,
A health food composition for improving skin wrinkles, comprising 20 parts by weight of the Geumhwagyu root extract based on 80 parts by weight of the radish extract.
상기 추출물은 물, 탄소수 1 내지 4의 저급알코올, 부틸렌글리콜, 프로필렌글리콜, 글리세린, 헥산, 메틸렌클로라이드, 에틸아세테이트 및 n-부탄올 중 1종 이상의 추출용매를 이용하여 수득된 것을 특징으로 하는, 피부 주름 개선용 건강식품 조성물.
8. The method of claim 7,
The extract is water, a lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin, hexane, methylene chloride, ethyl acetate and n-butanol, characterized in that obtained using one or more extraction solvents, skin A health food composition for wrinkle improvement.
무 추출물 80 중량부 기준 금화규 뿌리 추출물 20 중량부 포함하는 것을 특징으로 하는 피부 탄력 개선용 건강식품 조성물.
Geumhwagyu ( Hibiseu Smanihot L. ) root extract and radish ( Raphanus sativus var. hortensis for. acanthiformis MAKINO ) extract,
A health food composition for improving skin elasticity, comprising 20 parts by weight of the Geumhwagyu root extract based on 80 parts by weight of the radish extract.
상기 추출물은 물, 탄소수 1 내지 4의 저급알코올, 부틸렌글리콜, 프로필렌글리콜, 글리세린, 헥산, 메틸렌클로라이드, 에틸아세테이트 및 n-부탄올 중 1종 이상의 추출용매를 이용하여 수득된 것을 특징으로 하는, 피부 탄력 개선용 건강식품 조성물.
11. The method of claim 10,
The extract is water, a lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin, hexane, methylene chloride, ethyl acetate and n-butanol, characterized in that obtained using one or more extraction solvents, skin A health food composition for improving elasticity.
무 추출물 80 중량부 기준 금화규 뿌리 추출물 20 중량부 포함하는 것을 특징으로 하는 피부 주름 개선용 건강기능식품 조성물.
Geumhwagyu ( Hibiseu Smanihot L. ) root extract and radish ( Raphanus sativus var. hortensis for. acanthiformis MAKINO ) extract,
A health functional food composition for improving skin wrinkles, characterized in that it contains 20 parts by weight of the Geumhwagyu root extract based on 80 parts by weight of the radish extract.
상기 추출물은 물, 탄소수 1 내지 4의 저급알코올, 부틸렌글리콜, 프로필렌글리콜, 글리세린, 헥산, 메틸렌클로라이드, 에틸아세테이트 및 n-부탄올 중 1종 이상의 추출용매를 이용하여 수득된 것을 특징으로 하는, 피부 주름 개선용 건강기능식품 조성물.
14. The method of claim 13,
The extract is water, a lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin, hexane, methylene chloride, ethyl acetate and n-butanol, characterized in that obtained using one or more extraction solvents, skin A health functional food composition for wrinkle improvement.
무 추출물 80 중량부 기준 금화규 뿌리 추출물 20 중량부 포함하는 것을 특징으로 하는 피부 탄력 개선용 건강기능식품 조성물.
Geumhwagyu ( Hibiseu Smanihot L. ) root extract and radish ( Raphanus sativus var. hortensis for. acanthiformis MAKINO ) extract,
A health functional food composition for improving skin elasticity, comprising 20 parts by weight of the Geumhwagyu root extract based on 80 parts by weight of the radish extract.
상기 추출물은 물, 탄소수 1 내지 4의 저급알코올, 부틸렌글리콜, 프로필렌글리콜, 글리세린, 헥산, 메틸렌클로라이드, 에틸아세테이트 및 n-부탄올 중 1종 이상의 추출용매를 이용하여 수득된 것을 특징으로 하는, 피부 탄력 개선용 건강기능식품 조성물.17. The method of claim 16,
The extract is water, a lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin, hexane, methylene chloride, ethyl acetate and n-butanol, characterized in that obtained using one or more extraction solvents, skin A health functional food composition for improving elasticity.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20190172127 | 2019-12-20 | ||
KR1020190172127 | 2019-12-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210080180A KR20210080180A (en) | 2021-06-30 |
KR102431443B1 true KR102431443B1 (en) | 2022-08-12 |
Family
ID=76602509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200138343A KR102431443B1 (en) | 2019-12-20 | 2020-10-23 | Composition for improving skin wrinkles and elasticity containing the extract of Hibiseu Smanihot L. |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102431443B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240022246A (en) | 2022-08-11 | 2024-02-20 | (주)지에프씨생명과학 | Cosmetic composition containing vegetable low molecular collagen peptide as active ingredients, antioxidation, anti-inflammatory and anti0-wrinkle |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102626140B1 (en) * | 2021-10-13 | 2024-01-18 | 헤르바바이오(주) | Anti-pollution cosmetic composition containing camellia extract, aurea helianthus extract, carpinus tschonoskii extract, silkworm extract and centella asiatica extract |
KR20230080819A (en) | 2021-11-30 | 2023-06-07 | 한남대학교 산학협력단 | Antibacterial and antioxidant composition containing gold hibiscus extract |
KR20230111926A (en) | 2022-01-19 | 2023-07-26 | (주)3일애 | A cosmetic composition comprising vegetable collagens using natural microneedle, and a manufacturing process thereof |
KR102585340B1 (en) | 2022-07-11 | 2023-10-06 | (주)바른씨엔씨 | Method for manufacturing feminine hygiene pad using the extract of Abelmoschus manihot and feminine hygiene pad therefrom |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101857528B1 (en) | 2016-07-01 | 2018-05-15 | 에스케이바이오랜드 주식회사 | Cosmetic composition with the extract of Aurea Helianthus for skin-whitening |
KR20190116837A (en) * | 2018-04-05 | 2019-10-15 | 서원대학교산학협력단 | Composition Comprising Radish Extract for Improving Skin Wrinkle and Elasticity |
-
2020
- 2020-10-23 KR KR1020200138343A patent/KR102431443B1/en active IP Right Grant
Non-Patent Citations (3)
Title |
---|
박은영. 황촉규 지상부의 항산화 및 항염 활성. 숙명여자대학교 대학원 약학과 의약화학 및 천연물약학 전공 박사학위 논문, 2008.12월 |
뷰티는 파우더룸 네이버블로그. 메이드미 골드히비스커스 리스토어링 에센스, 2019.10.21. |
신상환. 황촉규 추출액 및 동결 건조제의 화장품소재의 응용. 중앙대학교 의약식품대학원 의약식품학과 향장품 및 향장산업전공 석사학위논문, 2012.08월 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240022246A (en) | 2022-08-11 | 2024-02-20 | (주)지에프씨생명과학 | Cosmetic composition containing vegetable low molecular collagen peptide as active ingredients, antioxidation, anti-inflammatory and anti0-wrinkle |
Also Published As
Publication number | Publication date |
---|---|
KR20210080180A (en) | 2021-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102431443B1 (en) | Composition for improving skin wrinkles and elasticity containing the extract of Hibiseu Smanihot L. | |
KR102113193B1 (en) | Composition for improving skin conditions comprising artemisiae annuae herba, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same | |
CN114929195A (en) | Composition containing plant extract | |
KR20150059551A (en) | Composition for improving skin conditions comprising panax ginseng sprout extract or fraction thereof and method for improving skin conditions using the same | |
KR102014312B1 (en) | Skin-whitening functional composition including polyopes affinis extracts | |
KR20140068679A (en) | Composition comprising extracts of white tea for the care of skin wrinkle | |
KR102439597B1 (en) | Composition for improving skin wrinkles and elasticity containing the extract of Raphanus sativus var. hortensis for. Acanthiformis MAKINO | |
KR102577528B1 (en) | Composition for improving skin | |
KR20170137560A (en) | Composition for improving skin condition comprising herb extracts mixture | |
JP3938693B2 (en) | Collagen production promoter, skin cosmetics and cosmetics | |
KR20100042090A (en) | Composition for whitening containing extract of jasminum grandiflorum | |
KR20100042086A (en) | Composition for whitening containing extract of cortex cinnamomi cassiae | |
KR20170025352A (en) | Composition for improving skin | |
JP4261571B2 (en) | Collagen production promoter, skin cosmetics and cosmetics | |
KR102570987B1 (en) | A composition comprising extract of Lilium hansonii | |
KR102286969B1 (en) | Composition for improving skin conditions comprising omega-7 derived from refined fish oil and red ginseng | |
KR102366932B1 (en) | Composition with Antioxidant, Anti-Inflammation, Skin Moisturizing, Anti-Wrinkle, and Skin Regeneration Property Comprising Complex Extract of Hibiscus Syriacus Softened Petal as Active Ingredient | |
KR102290291B1 (en) | Composition for improving moisturizing skin containing fermented blueberry and black rice extracts | |
KR20180072381A (en) | Composition for improving skin condition comprising extract of Pisum sativum var. arvense (L.) Poir. | |
JP4261572B2 (en) | Collagen production promoter, skin cosmetics and cosmetics | |
KR102244585B1 (en) | Complex cosmetic composition for improving skin-aging | |
KR101872340B1 (en) | Skin whitening composition comprising Achyranthesjaponica Nakai extracts | |
KR20170137432A (en) | Composition for improving skin condition comprising herb extracts mixture | |
JP2003212781A (en) | Hyaluronic acid production promoter, skin cosmetic and food and beverage for beautification | |
KR20220046162A (en) | Composition for improving skin conditions comprising the extract of Allium ulleungense |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |